Security key
85205L107
SPRINGWORKS THERAPEUTICS, INC. - Common Stock, par value $.0001 per share (SWTX)
CUSIP: 85205L107
Q4 2024 13F Holders as of 31 Dec 2024
- Security type / class
- Equity / Common Stock, par value $.0001 per share
- Total 13F shares
- 80,867,369
- Total 13F value
- $2,921,793,248
- Share change
- -4,169,513
- Put/Call ratio
- 149%
- SEC-reported price per share
- $36.13
- Number of holders
- 214
- Value change
- -$118,091,155
- Number of buys
- 115
- Number of sells
- 107
- Shares outstanding
- 75,607,738
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q4 2024
Institutions
214
Top holders
10
SWTX full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q4 2025
SpringWorks Therapeutics, Inc. SEC filings
SpringWorks Therapeutics, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 85205L107
Recent filing periods:
Ownership snapshot
Top reported holders of SWTX - SPRINGWORKS THERAPEUTICS, INC. - Common Stock, par value $.0001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
VANGUARD GROUP INC
Disclosed value leader
FMR LLC
Comparable rows
15/15
Latest evidence
31 Dec 2024
13D/G
13F
3/4/5
Lead comparable stake: 9.6%
13D/G row: VANGUARD GROUP INC
Showing 1-6 of 15 holder rows.
Quick read
VANGUARD GROUP INC leads the comparable SEC ownership view at 9.6%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens VANGUARD GROUP INC's linked filing trail.
Comparable ownership
Top 5
VANGUARD GROUP INC
9.6%
Deep Track Capital, LP
4.6%
FMR LLC
15%
BlackRock, Inc.
7.9%
PRICE T ROWE ASSOCIATES INC /MD/
4.7%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| VANGUARD GROUP INC |
13D/G
13F
The Vanguard Group · Company
|
9.6%
|
$331,026,195
7,158,871 shares
|
$0 | 31 Dec 2024 |
| Deep Track Capital, LP |
13D/G
13F
Company
|
4.6%
|
$160,025,357
3,460,756 shares
|
$0 | 31 Dec 2024 |
| FMR LLC |
13F
Company
|
15%
|
$356,955,910
11,140,946 shares
|
— | 30 Sep 2024 |
| BlackRock, Inc. |
13F
Company
|
7.9%
|
$190,375,177
5,941,797 shares
|
— | 30 Sep 2024 |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
Company
|
4.7%
|
$112,667,000
3,516,418 shares
|
— | 30 Sep 2024 |
| Boxer Capital, LLC |
13F
Company
|
4.5%
|
$109,626,174
3,421,541 shares
|
— | 30 Sep 2024 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q4 2024
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
214
Shares
80,867,369
Rows available
214
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q4 2024 vs Q4 2025 Across Filers
Q4 2025 holders
2
Q4 2024 holders
214
Holder diff
212
| Investor | Q4 2025 Shares | Q4 2024 Shares | Share Diff | Share Chg % | Q4 2025 value | Q4 2024 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend